Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
British Journal of Neurosurgery
|
November 8, 2023
Patient selection and outcome of deep brain stimulation for multiple sclerosis-associated tremor
Menaka Pasangy Paranathala, Russell Mills, Priya Rai, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 22, 2004
Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis
Ho Jin Kim, Igal Ifergan, Jack P Antel, et al.
Patient Preference and Adherence
|
January 6, 2017
The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction
Mar Tintoré, Maggie Alexander, Kathleen Costello, et al.
Neuropsychology Review
|
May 7, 2021
Neurostructural and Neurophysiological Correlates of Multiple Sclerosis Physical Fatigue: Systematic Review and Meta-Analysis of Cross-Sectional Studies
Paula M Ellison, Stuart Goodall, Niamh Kennedy, et al.
Neurodegenerative Disease Management
|
November 25, 2020
Living with secondary progressive multiple sclerosis in Europe: perspectives of multiple stakeholders
Øivind Torkildsen, Ralf A Linker, Jose Mm Sesmero, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 20, 2017
An observational study of alemtuzumab following fingolimod for multiple sclerosis
Mark Willis, Owen Pearson, Zsolt Illes, et al.
Journal of Neurology
|
October 9, 2021
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis
Massimo Filippi, Romano Danesi, Tobias Derfuss, et al.
Brain : a Journal of Neurology
|
September 25, 2003
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis
Amit Bar-Or, Robert K Nuttall, Martin Duddy, et al.
The Lancet. Neurology
|
April 6, 2015
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator
Jacqueline Palace, Martin Duddy, Thomas Bregenzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 23, 2003
Determinants of human B cell migration across brain endothelial cells
Andrea Alter, Martin Duddy, Sherry Hebert, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
British Journal of Neurosurgery
|
November 8, 2023
Patient selection and outcome of deep brain stimulation for multiple sclerosis-associated tremor
Menaka Pasangy Paranathala, Russell Mills, Priya Rai, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 22, 2004
Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis
Ho Jin Kim, Igal Ifergan, Jack P Antel, et al.
Patient Preference and Adherence
|
January 6, 2017
The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction
Mar Tintoré, Maggie Alexander, Kathleen Costello, et al.
Neuropsychology Review
|
May 7, 2021
Neurostructural and Neurophysiological Correlates of Multiple Sclerosis Physical Fatigue: Systematic Review and Meta-Analysis of Cross-Sectional Studies
Paula M Ellison, Stuart Goodall, Niamh Kennedy, et al.
Neurodegenerative Disease Management
|
November 25, 2020
Living with secondary progressive multiple sclerosis in Europe: perspectives of multiple stakeholders
Øivind Torkildsen, Ralf A Linker, Jose Mm Sesmero, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 20, 2017
An observational study of alemtuzumab following fingolimod for multiple sclerosis
Mark Willis, Owen Pearson, Zsolt Illes, et al.
Journal of Neurology
|
October 9, 2021
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis
Massimo Filippi, Romano Danesi, Tobias Derfuss, et al.
Brain : a Journal of Neurology
|
September 25, 2003
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis
Amit Bar-Or, Robert K Nuttall, Martin Duddy, et al.
The Lancet. Neurology
|
April 6, 2015
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator
Jacqueline Palace, Martin Duddy, Thomas Bregenzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 23, 2003
Determinants of human B cell migration across brain endothelial cells
Andrea Alter, Martin Duddy, Sherry Hebert, et al.
Page
of 5